A team of Western researchers has developed a simple test—faster and more accurate than any approved thus far in Canada—to determine who has developed COVID-19 antibodies.
Jan 18, 2021
0
7
The most severe cases of COVID-19 begin with leaky blood vessels. Breaches in the vascular system cause inflammation and coagulation, as fluid floods the lungs. Meanwhile, a host of seemingly unrelated symptoms set in. Blood ...
Jan 18, 2021
0
71
Nearly 38 million people around the world are living with HIV, which, with access to treatment, has become a lifelong chronic condition. Understanding how infection changes the brain, especially in the context of aging, is ...
Jan 15, 2021
0
54
A year after the coronavirus pandemic roared into the United States, the therapeutic options for COVID-19 remain limited, reinforcing the vital importance of the new vaccines.
Jan 11, 2021
0
3
Blood plasma from people recovering from COVID-19 could help prevent severe illness in older patients newly infected with the virus, a small new Argentinian study finds.
Jan 7, 2021
1
4
(HealthDay)—The American Red Cross is urging COVID-19 survivors to donate blood plasma for hospital patients who need it to recover.
Jan 6, 2021
0
0
Researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health, have shown that isatuximab, a monoclonal antibody approved ...
Dec 8, 2020
0
4
(HealthDay)—Early in the COVID-19 pandemic, anecdotal reports suggested that infusing very sick patients with the blood plasma of people who'd survived the disease might help boost outcomes.
Nov 25, 2020
0
2
Unlike so many other deadly viruses, HIV still lacks a vaccine. The virus—which continues to infect millions around the world—has proven especially tricky to prevent with conventional antibodies, in part because it evolves ...
Nov 19, 2020
0
72
Although the vaccine cavalry is finally coming over the hill, the need for better drugs to treat those with COVID-19 remains.
Nov 17, 2020
0
7
